Published in Pharma Law Weekly, November 29th, 2005
Despite these new findings, the majority of respondents (67%) believe that clinical research studies are safe or somewhat safe which is virtually identical to numbers reported in the CISCRP/ODC December 2004 survey.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.